Related Experiment Videos

The tumor suppressor protein p16INK4a

M Serrano1

  • 1Department of Immunology and Oncology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain. mserrano@cnb.uam.es

Experimental Cell Research
|January 7, 1998
PubMed

Insights

The tumor suppressor p16INK4a protein is crucial for cell-cycle control and cancer. Its inactivation in tumors and inherited mutations increase cancer risk, highlighting its role in cancer susceptibility.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The p16INK4a (inhibitor of CDK4) protein acts as a critical tumor suppressor.
  • p16INK4a is a key regulator of the cell cycle, directly linking it to cancer development.
  • The p16INK4a gene is frequently inactivated in various human cancers.

Purpose of the Study:

  • To elucidate the role of the p16INK4a tumor suppressor in cell-cycle regulation.
  • To understand the implications of p16INK4a gene inactivation in human tumors.
  • To investigate the mechanisms governing p16INK4a regulation.

Main Methods:

  • Analysis of p16INK4a gene status in human tumors.
  • Study of cell-cycle regulatory pathways involving p16INK4a and Rb.
  • Characterization of molecular mechanisms controlling p16INK4a expression.

Main Results:

  • Frequent inactivation of the p16INK4a gene observed in human tumors.
  • Inheritance of mutant p16INK4a alleles confers susceptibility to multiple cancer types.
  • p16INK4a functions within a pathway converging on the Rb tumor suppressor.

Conclusions:

  • p16INK4a is a pivotal tumor suppressor with a direct role in cell-cycle control.
  • Alterations in p16INK4a are significant factors in cancer development and susceptibility.
  • Further research into p16INK4a regulatory mechanisms is essential for understanding cancer biology.

Related Concept Videos